Journal Guide

SAHARA-J is an international Open Access journal disseminating vital research on social factors relating to HIV/AIDS. Areas covered include care, support, behaviour change, behavioural surveillance, counselling, impact, mitigation, stigma, discrimination, prevention, treatment, adherence, culture, faith-based approaches, evidence-based intervention, health communication, structural and environmental intervention, financing, policy, media and more. SAHARA-J publishes peer-reviewed contributions of the highest quality from researchers in Sub-Saharan Africa and other developing countries around the world. SAHARA J has a unique reputation for editorial excellence and integrity, who maintain an active interest in all aspects of HIV/AIDS. The readership of the Journal varies from academics, scholars to researchers. Internet users such as Journalists, international organizations, policy makers, civil society, donors and PLWHA also have free access to the Journal. SAHARA-J ensures that policy makers are well informed, help coordinate social aspects of HIV/AIDS research, minimizes duplication and build the community of social aspects of HIV/AIDS researchers. Its objectives are: • To influence policy and responses through the production and dissemination of evidence-based research on social aspects of HIV/AIDS. • To provide a publication source for all aspects of HIV/AIDS in Africa. • To disseminate free HIV/AIDS information in Africa. The journal is published by Routledge on behalf of SAHARA, the Social Aspects of HIV/AIDS Research Alliance, which is part of the Human Sciences Research Council (HSRC). SAHARA is an alliance of partners established to conduct, support and use social sciences research to prevent the further spread of HIV and mitigate the impact of its devastation in sub-Saharan Africa. .

Scandinavian Journal of Infectious Diseases publishes original papers on clinical aspects of infectious diseases. The topics may concern clinical aspects of infectious diseases, laboratory investigations of clinical significance (bacteriological, virological, parasitological, mycological, immunological, pathological, physiological, chemical and pharmacological), epidemiological and epizootological studies of human infections and experimental infections. Manuscripts are welcomed both from Scandinavian and other countries. In addition to regular articles, review articles, case reports, short communications and letters may be accepted. The journal was started in 1969 and was the first European journal in English entirely devoted to the clinical and microbiological aspects of infectious diseases. Read More: http://informahealthcare.com/page/inf/Description.

Sexual Health publishes original and significant contributions to the fields of sexual health including HIV/AIDS, Sexually transmissible infections, issues of sexuality and relevant areas of reproductive health. This journal is directed towards those working in sexual health as clinicians, public health practitioners, researchers in behavioural, clinical, laboratory, public health or social, sciences. The journal publishes peer reviewed original research, editorials, review articles, topical debates, case reports and critical correspondence. Authors interested in preparing a feature article, a mini-review or a viewpoint article are invited to discuss the matter with the Editor.

Sexually Transmitted Diseases, the official journal of the American Sexually Transmitted Diseases Association, publishes peer-reviewed, original articles on clinical, laboratory, immunologic, epidemiologic, behavioral, public health, and historical topics pertaining to sexually transmitted diseases and related fields. Reports from the CDC and NIH provide up-to-the-minute information. A highly respected editorial board is composed of prominent scientists who are leaders in this rapidly changing field. Included in each issue are studies and developments from around the world.Journal articles posted prior to 12 months of current issue is freely accessible.Indexed/abstracted in: MEDLINE/PUBMED, EMBASE, SCOPUS, International Pharmaceutical Abstracts (IPA), BIOSIS Previews, Science Citation Index Expanded, Current Contents/Clinical Medicine and Life Sciences, Chemical Abstracts.

Sexually Transmitted Infections is the world's longest running international journal on sexual health. It aims to keep practitioners, trainees and researchers up to date in the prevention, diagnosis and treatment of all STIs and HIV. The journal publishes original research, evidence based reviews and comment on the clinical, epidemiological, sociological and laboratory aspects of sexual health from around the world. We also publish educational articles, letters and other material of interest to readers, along with podcasts and other online material. STI provides a high quality editorial service from submission to publication.

Thomson Reuters is proud to sponsor Canadian golf champion Mike Weir, the Formula One TM (F1 TM ) team–AT&T Williams, and the Lawn Tennis Association (LTA). While these sponsorships span different sports genres and countries, they all embody Thomson Reuters core values: global business collaboration is key; people make the difference; and performance matters.

Focus and Scope

The Southern African Journal of Infectious Diseases (SAJID), formerly called the Southern African Journal of Epidemiology and Infection (SAJEI), first appeared in 1985 as a joint publication of the Infectious Diseases Society of Southern Africa (IDSSA), the Sexually Transmitted Diseases Society of Southern Africa (STDSSA) and the Epidemiology Society of Southern Africa, the latter having subsequently been succeeded by the Public Health Association of South Africa (PHASA). Presently SAJID is published under the auspices of the Federation of Infectious Diseases Societies of South Africa which is an umbrella organization incorporating IDSSA, STDSSA as well as the Infection Control Society of South Africa (ICASA), the National Antibiotic Study Forum (NASF) of South Africa, and the South African Society of Travel Medicine (SASTM).

Publications of SAJID centre round aspects of epidemiology and infection, particularly those of importance to the societies of FIDSSA. Topics around infection include clinical and epidemiological aspects of communicable diseases, laboratory diagnosis of infections, characterisation of infective agents by molecular techniques and the study of transmission patterns of pathogens in institutional and community settings. Other infection related studies cover surveillance of vaccine-controllable and other infectious diseases, drug susceptibility patterns of hospital-acquired and community-acquired pathogens and infection control strategies for the southern Africa region. SAJID also promotes greater collaboration between clinically oriented and laboratory-based divisions within the FIDSSA societies, and the establishment of quality assurance programmes and other measures to enhance and maintain standards of diagnostic and public health microbiology.

Scientific papers in the SAJID aim to advance the understanding of all aspects of epidemiology, public health, clinical microbiology and infection. The journal strives to promote research and exchange of information on specific areas of infectious diseases, medical microbiology and virology, covering fields of interest of the societies of FIDSSA and PHASA. Manuscripts describing research performed at southern African institutions and in southern African settings enjoy a high priority, as do health matters covering Africa and the developing world, as well as global issues such as malaria and other tropical diseases, tuberculosis, sexually transmitted infections and HIV/AIDS. The scope of interest of SAJID is wide but the journal aims to maintain and improve the standard of its publications.

The SAJID’s subscribes to the Uniform Requirements of the International Committee of Medical Journal Editors (ICMJE) (www. icmje.org). which state the ethical principles in the conduct and reporting of research and provide recommendations relating to specific elements of editing and writing.

Ethics

The SAJID abides by the high ethical standards of the Commission on Public Ethics (COPE) (www.publicationethics.org) and ICMJE. Falsification or fabrication of data, plagiarism, including duplicate publication of the author’s own work without proper citation, and misappropriation of the work are unacceptable practices.

Originality

SAJID will not publish manuscripts that overlap substantially with articles already published or accepted for publication, whether in print or the electronic media, even if the new submission contains data not included in the published or accepted work. This policy does not preclude consideration of a report that follows a presentation at a meeting/conference or expands preliminary findings published or presented as an abstract. Submissions for republication of articles must be accompanied by a statement that the article is republished with the knowledge of the author and Editor and the permission of the original copyright holder.

Plagiarism

Plagiarism, including duplicate publication of the author’s own work, in whole or in part without proper citation, will not be tolerated by the SAJID. If an attempt at undisclosed duplicate publication is identified, the article will be rejected, the owners of the copyright notified and the violation may be reported to FIDSSA or PHASA.

The journal will also consider applications where health care provision is the focus. Coverage of veterinary topics will be included, and those with direct human health implications are especially welcome. The journal places special emphasis on spatio-temporal aspects of emerging diseases (e.g., avian flu, SARS), development of spatial statistical and computational methods, and novel applications of geospatial technology (e.g., GPS, GIS) for shedding insights on exposure and disease processes.

The journal accepts three different types of submissions:
1. Methods papers that outline new methodology in the areas of GIS, spatial statistics, exposure science, and/or epidemiology;
2. Case Study/Applications papers where recently developed methodology is applied to novel applications with a clear exposure/disease focus; and
3. Short reports where a) they are around 4-8 text pages in length b) they focus on an important novel development and c) the development should be capable of description within the page length. Case Studies progress reports in the form of 'what we have done so far' are not acceptable as Short Reports unless they comply with b) or c) above.

Surgical Infections provides practicing surgeons, infectious disease specialists, and investigators with comprehensive and authoritative information on the biology, prevention, and management of post-operative infections. Original articles cover the latest advancements, new therapeutic management strategies, and translational research that is being applied successfully to improve clinical outcomes. Surgical Infections also provides an understanding of immune and inflammatory responses, which is critical for surgeons to treat post-operative infections effectively.

The American Journal of Tropical Medicine and Hygiene is a peer-reviewed journal published monthly by the American Society of Tropical Medicine and Hygiene and consists of two complete, sequentially numbered volumes each calendar year. The journal is made freely available to non-profit institutions in developing countries through our particpation in HINARI.

To publish relevant documents in the area of microbiology, infection and immune response to infectious agents.

Published continuously since 1904, The Journal of Infectious Diseases (JID) is the premier global journal for original research on infectious diseases. The editors welcome Major Articles and Brief Reports describing research results on microbiology, immunology, epidemiology, and related disciplines, on the pathogenesis, diagnosis, and treatment of infectious diseases; on the microbes that cause them; and on disorders of host immune responses. JID is an official publication of the Infectious Diseases Society of America.

The Lancet HIV launched in September 2014 as an exclusively online journal, publishing original research, expert commentary, informative editorials, and timely correspondence. The monthly journal provides readers with context and insight into the clinical advances and practice-changing research shaping the study of HIV/AIDS today.

Now is a critical moment in the fight against HIV/AIDS. Despite the world view that the end of AIDS may be within reach, the job of controlling this epidemic is certainly not done. As HIV disease evolves to become a chronic infection, the interaction of the virus with other chronic conditions will present a host of new challenges.The Lancet HIV is a journal for a new era in the history of HIV/AIDS.

The Lancet HIV builds onThe Lancet journals' reputation for publishing HIV/AIDS research to provide a reliable foundation for advocacy and for programmatic and political change. We will consider clinical, epidemiological, operational, and implementation research, unifying these disciplines across a single vision for the health of those living with HIV.

Following inThe Lancet tradition, the journal is stringently edited and peer-reviewed to ensure scientific merit and clinical relevance. All original research is Fast Track peer reviewed for online publication within 8 weeks of submission and receives global exposure to the medical HIV/AIDS community via our online platforms thelancet.com and ScienceDirect. For selected high-impact research, the journal has a dedicated press office to facilitate worldwide media coverage, ensuring extensive global exposure of your research.

Visit http://www.thelancet.com/hiv for more information.

The Lancet Infectious Diseases is recognized for providing a global, authoritative, and independent forum for the highest quality infectious diseases research and opinion, covering the research and treatment of diseases and conditions such as HIV/AIDS, healthcare association infections, antibiotic resistance, malaria, tuberculosis, emerging infections, and public health. The Lancet Infectious Diseases publishes original research, reviews, personal views, commentaries, and news across the global field of infectious diseases. The journal is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. All original research is fast-tracked to publication within 8 weeks on average of submission and published first online on TheLancet.com before the print issue.